Skip to main content
. 2003 Apr;52(4):523–526. doi: 10.1136/gut.52.4.523

Figure 1.

Figure 1

Interleukin 1β (IL-1β) mRNA expression in (A) post-infectious irritable bowel syndrome patients (INF-IBS) and in (B) post infection controls (INF-CON) (2% agarose gel stained with ethidium bromide; 30 polymerase chain reaction cycles). INF-IBS patients developed IBS after acute gastroenteritis and INF-CON patients returned to normal bowel habits after acute gastroenteritis